4.7 Article

Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3

Journal

CELL DEATH AND DIFFERENTIATION
Volume 28, Issue 10, Pages 2871-2887

Publisher

SPRINGERNATURE
DOI: 10.1038/s41418-021-00789-w

Keywords

-

Funding

  1. National Natural Science Foundation of China [81803521, 81872860, 82003710, 82070464]
  2. Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01Y093]
  3. National Major Special Projects for the Creation and Manufacture of New Drugs [2019ZX09301104]
  4. National Engineering and Technology Research Center for New drug Druggability Evaluation [2017B090903004]
  5. Special Program for Applied Science and Technology of Guangdong Province [2015B020232009]
  6. Natural Science Foundation of Guangdong Province [2019A1515010273, 2021B1515020100]
  7. Fundamental Research Funds for the Central Universities [19ykpy131]

Ask authors/readers for more resources

The study reveals that SNX3 plays a key role in cardiac function and is crucial for myocardial injury, suggesting that SNX3 could be a potential therapeutic target for cardiac hypertrophy and heart failure.
Sorting nexins (SNXs), the retromer-associated cargo binding proteins, have emerged as critical regulators of the trafficking of proteins involved in the pathogenesis of diverse diseases. However, studies of SNXs in the development of cardiovascular diseases, especially cardiac hypertrophy and heart failure, are lacking. Here, we ask whether SNX3, the simplest structured isoform in the SNXs family, may act as a key inducer of myocardial injury. An increased level of SNX3 was observed in failing hearts from human patients and mice. Cardiac-specific Snx3 knockout (Snx3-cKO) mice and Snx3 transgenic (Snx3-cTg) mice were generated to evaluate the role of Snx3 in myocardial hypertrophy, fibrosis, and heart function by morphology, echocardiography, histological staining, and hypertrophic biomarkers. We report that Snx3-cKO in mice significantly protected against isoproterenol (ISO)-induced cardiac hypertrophy at 12 weeks. Conversely, Snx3-cTg mice were more susceptible to ISO-induced cardiac hypertrophy at 12 weeks and showed aggravated cardiac injury even heart failure at 24 weeks. Immunoprecipitation-based mass spectrometry, immunofluorescent staining, co-immunoprecipitation, localized surface plasmon resonance, and proximity ligation assay were performed to examine the direct interaction of SNX3-retromer with signal transducer and activator of transcription 3 (STAT3). We discovered that STAT3 was a new interacting partner of SNX3-retromer, and SNX3-retromer served as an essential platform for assembling gp130/JAK2/STAT3 complexes and subsequent phosphorylation of STAT3 by direct combination at EE. SNX3-retromer and STAT3 complexes were transiently imported into the nucleus after hypertrophic stimuli. The pharmacological inhibition or knockdown of STAT3 reversed SNX3 overexpression-induced myocardial injury. STAT3 overexpression blunts the beneficial function of SNX3 knockdown on hypertrophic cardiomyocytes. We show that SNX3-retromer promoted importin alpha 3-mediated STAT3 nuclear trafficking and ultimately leading to cardiac injury. Taken together, our study reveals that SNX3 plays a key role in cardiac function and implicates SNX3 as a potential therapeutic target for cardiac hypertrophy and heart failure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available